EUVIMEDEUVIMED entdecken
Crossref

Disparities in Pancreatic Cancer Survival: The Overlooked Role of Demographic and Socioeconomic Factors

Jason Pieri, Courtney Day, Aaron Spaulding iD, Mary Tice, Cornelius A Thiels, Zhi Ven Fong, John A Stauffer, Katherine E Poruk

Journal of Surgical Oncology · 21.08.2026

DOI: 10.1002/jso.70377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 21.08.2026. Verfasst von Jason Pieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA. Die Arbeit nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Pancreatic ductal adenocarcinoma (PDAC) remains highly lethal, but the contribution of nonbiological factors to long‐term survival is unclear. We evaluated demographic, socioeconomic, clinical, treatment, and care‐delivery factors associated with 3‐year survival and whether these associations persisted at 5 years.

Methods

National Cancer Database patients with stage I–III PDAC diagnosed from 2012 to 2022 were analyzed using multivariable logistic regression adjusted for treatment pathway.

Results

Among 57,053 patients, 51,071 were eligible for a 3‐year analysis, and 12,205 (23.9%) survived. Compared with chemotherapy alone, surgery with chemotherapy (OR, 7.12; 95% CI, 6.64–7.63) and surgery alone (OR, 3.84; 95% CI, 3.49–4.23) had the strongest associations with survival. Younger age, lower comorbidity, Asian race, Spanish/Hispanic ethnicity, private insurance, lower grade, body or tail location, and lower nodal burden were independently associated with survival. Black race and treatment timing were not significant after adjustment. Findings were directionally consistent at 5 years.

Conclusion

Demographic, socioeconomic, and clinical factors independently influence 3‐year survival in PDAC. These findings underscore the need to complement biologic and therapeutic advances with structural interventions, such as insurance expansion and improved access to high‐quality centers, to mitigate disparities and improve outcomes in this highly lethal cancer.

Autor:innen und Institutionen

  • Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA.
  • Department of Surgical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Surgical Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA.
  • Department of Surgical Oncology, Mayo Clinic, Scottsdale, Arizona, USA.

ORCID-Profile: Aaron Spaulding

Zitieren

APA

Pieri, J., Day, C., Spaulding, A., Tice, M., Thiels, C. A., Fong, Z. V., Stauffer, J. A., & Poruk, K. E. (2026). Disparities in Pancreatic Cancer Survival: The Overlooked Role of Demographic and Socioeconomic Factors. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70377

Vancouver

Pieri J, Day C, Spaulding A, Tice M, Thiels CA, Fong ZV, et al. Disparities in Pancreatic Cancer Survival: The Overlooked Role of Demographic and Socioeconomic Factors. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70377

BibTeX
@article{Pieri2026,
  author = {Pieri, Jason and Day, Courtney and Spaulding, Aaron and Tice, Mary and Thiels, Cornelius A and Fong, Zhi Ven and Stauffer, John A and Poruk, Katherine E},
  title = {Disparities in Pancreatic Cancer Survival: The Overlooked Role of Demographic and Socioeconomic Factors},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  doi = {10.1002/jso.70377}
}
Kostenlos starten →